Anzeige
Mehr »
Login
Donnerstag, 07.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
447 Leser
Artikel bewerten:
(2)

Grayhawk Wealth Welcomes Claire Lynch as Relationship Lead, Western Canada

TORONTO, ON / ACCESSWIRE / January 18, 2021 / Grayhawk Wealth ("Grayhawk") is proud to announce the appointment of Claire Lynch as Relationship Lead, Western Canada to its growing team.

Claire joins the company's growing Western Canada division, bringing to the firm over 20 years of experience in high-touch relationship management and business development in both the non-profit and corporate sectors.

"Claire's arrival at Grayhawk demonstrates our commitment to deepening our relationships and growing our business in Western Canada. Her vast network of connections and proven track record in development makes her an ideal fit for our expanding team," said Michael Kaumeyer, Co-CEO of Grayhawk.

Claire brings to Grayhawk a unique combination of skills in family governance, facilitation, philanthropy, business development and multi-generational family enterprise. Most recently, she served as the Vancouver-based Vice-President of Membership for Canada at TIGER 21, where she was responsible for supporting the Canadian growth of the boutique peer-learning organisation for HNW entrepreneurs and investors.

Her previous roles include serving as Director of Development at the Mulgrave IB World School in Vancouver, as CEO of the Irish Hospice Foundation in Dublin, Ireland, and as Director of Development at GAP Activity Projects Ltd., based in London, England.

In the past, Claire has been an advocate and volunteer with palliative and hospice care services in Canada and Ireland. She was also a Director with the West Vancouver Community Foundation, assisting with their fundraising efforts.

"I'm honoured to have the opportunity to work with a growing business committed to creating long term positive impact for the families they work with," said Lynch. "I look forward to drawing on my diverse career experiences in this new role and to helping Grayhawk reach new heights."

About Grayhawk

Grayhawk Investment Strategies Inc. ("Grayhawk Wealth") ("Grayhawk") works with foundations, institutions and families with multi-generational wealth on their financial and human capital understanding that they need more than an investment plan, they need a strategy to build well-being that lasts. The company is guided by this mission to build trust with families, as well as foundation and institution advisors, that want to look to the future and benefit from the real value of wealth. Grayhawk serves successful Canadian clients with custom portfolio management services, a family office and unique affinity partnerships from its offices in Calgary, Montreal and Toronto. For more information about Grayhawk, visit grayhawkwealth.com.

Grayhawk Investment Strategies Inc. is registered as a Portfolio Manager and Exempt Market Dealer in Alberta, British Columbia, Manitoba, Nova Scotia, Ontario, Québec and Saskatchewan and as an Investment Fund Manager in Alberta, Ontario and Québec.

Contact:

Adam Daifallah
Sagard Holdings
Work: +1 514.316.7089
media@sagardholdings.com

Cautionary Note Regarding Forward-Looking Information

This release contains forward-looking information. Such forward-looking statements or information are provided for the purpose of providing information about Grayhawk's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes. Any such forward-looking information may be identified by words such as "proposed", "expects", "intends", "may", "will", and similar expressions.

Forward-looking statements or information are based on a number of factors and assumptions which have been used to develop such statements and information, but which may prove to be incorrect. Although Grayhawk believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Grayhawk can give no assurance that such expectations will prove to be correct. The forward-looking information in this release reflects the current expectations, assumptions and/or beliefs of Grayhawk based on information currently available to Grayhawk.

Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Grayhawk disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. The forward-looking statements or information contained in this press release are expressly qualified by this cautionary statement.

SOURCE: Grayhawk Wealth



View source version on accesswire.com:
https://www.accesswire.com/624531/Grayhawk-Wealth-Welcomes-Claire-Lynch-as-Relationship-Lead-Western-Canada

© 2021 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.